El interés en corto de HCW Biologics da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de HCW Biologics. Los datos de interés en corto se actualizan cada dos semanas.

HCW Biologics (NASDAQ:HCWB) Bolsa, Informe de interés en corto

HCW Biologics

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

HCW Biologics Inc

STOCK RISES THOUGHT THE DAY AND HITS HIGH AT 3:55 PM EDT
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="822" height="799" src="https://contributor-assets.benzinga.com/wp-content/uploads/2024/09/30203158/Screen-Shot-2024-09-30-at-4.28.14-PM.png" alt="" class="wp-image-1697" style="width:624px" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2024/09/30203158/Screen-Shot-2024-09-30-at-4.28.14-PM.png 822w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/09/30203158/Screen-Shot-2024-09-30-at-4.28.14-PM-300x292.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/09/30203158/Screen-Shot-2024-09-30-at-4.28.14-PM-768x747.png 768w" sizes="(max-width: 822px) 100vw, 822px" /></figure>
ELI LILLY Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions. 
Today, at 10:10 AM on September 30th, a significant trading signal occurred for Eli Lilly, Inc. as it demonstrated a Power Inflow at $872. This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" moves in the market. They see the value of utilizing order flow analytics to guide their trading decisions. The Power Inflow points to a possible uptrend in Amazon&#8217;s stock, marking a potential entry point for traders looking to capitalize on the expected upward movement. Traders with this signal closely watch for sustained momentum in Amazon&#8217;s stock price, interpreting this event as a bullish sign.
Signal description
Order flow analytics, aka transaction or market flow analysis, separate and study both the retail and institutional volume rate of orders (flow). It involves analyzing the flow of buy and sell orders, along with size, timing, and other associated characteristics and patterns, to gain insights and make more informed trading decisions. This particular indicator is interpreted as a bullish signal by active traders.&nbsp;
The Power Inflow occurs within the first two hours of the market open and generally signals the trend that helps gauge the stock&#8217;s overall direction, powered by institutional activity in the stock, for the remainder of the day.&nbsp;
By incorporating order flow analytics into their trading strategies, market participants can better interpret market conditions, identify trading opportunities, and potentially improve their trading performance. But let's not forget that while watching smart money flow can provide valuable insights, it is crucial to incorporate effective risk management strategies to protect capital and mitigate potential losses. Employing a consistent and effective risk management plan helps traders navigate the uncertainties of the market in a more controlled and calculated manner, increasing the likelihood of long-term success
If you want to stay updated on the latest options trades for LLY, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.&nbsp;
<a href="https://benzinga.com/apis?_gl=1&#x2A;1hlgn5i&#x2A;_ga&#x2A;MTY1NjE2NTYxMi4xNzE0NzQ4MTAy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDc0ODEwMi4xLjEuMTcxNDc0ODQyOC4wLjAuMA..">Market News and Data brought to you by Benzinga APIs</a> and include firms, like <a href="https://finitusa.com/en/">Finit USA</a>, responsible for parts of the data within this article. 
&#xA9; 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
After Market Close UPDATE:
The price at the time of the Power Inflow was $872. The returns on the High price ($887.07) and Close price ($885.94) after the Power Inflow are respectively 1.6% and 1.5%. The result underlines the importance of a trading plan that includes Profit Targets and Stop Losses that reflect your appetite for risk. The results were close today but that is not always the case.
Past results are not indicative of future results

Signals

Markets

General

Tradepulse Power Inflow Alert: Eli Lilly And Company Climbs 15 Points

With no more presidential debates planned between Vice President Kamala Harris and Donald Trump, the attention turns to their vice presidential running mates Minnesota Gov. Tim Walz and Ohio Sen. J.D. Vance, who are the candidates for the Democratic and Republican parties, respectively, in<a href="https://www.benzinga.com/topic/2024-election"> the 2024 election.</a>
The two face off in a debate Tuesday, Oct. 1. Here's a look at how to watch, what could be the big topics and who bettors are predicting will win.
How to Watch the VP Debate: Vance and Walz face off on Oct. 1 at 9 p.m. ET <a href="https://www.benzinga.com/general/politics/24/09/40844701/trump-harris-might-not-debate-again-but-their-running-mates-will-what-voters-should-know-about-w">in a debate hosted by </a>CBS News, a unit of Paramount Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NASDAQ">PARA</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARAA#NASDAQ">PARAA</a>).
Norah O'Donnell and Margaret Brennan will serve as the moderators for the debate, which takes place in New York without a live audience.
CBS News begins coverage of the debate at 8 p.m. ET on CBS and affiliate networks. The debate and coverage can also be streamed on Paramount+, CBSNews.com and YouTube. Paramount will allow simulcasting by other networks.
The debate will be 90 minutes in length with two planned four-minute commercial breaks. The candidates are not allowed to interact with their campaign teams during the commercial breaks.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent093024">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Debate Rules: The candidates will not give opening statements for the vice-presidential debate on Tuesday. The candidates will be given questions with two minutes to answer and then given two minutes to respond. One minute will be allowed for rebuttals, as well.
Walz will stand behind the lectern on the left side of the stage with Vance at the podium on the right side of the stage.
Candidates will not be allowed to have pre-written notes on the stage with them.
One major difference from the recent presidential debate between Harris and Trump will be microphones for the candidates that are not muted. The moderators will have the ability to turn off the microphones if warranted by CBS News.
The winner of a coin toss, Vance will go second in Tuesday's closing statements. Each candidate will have two minutes for their closing statement to end the debate.
Key Items to Watch: With less than 40 days until the Nov. 5 presidential election, Tuesday's debate could prove as a final test for undecided voters and voters who are less convinced of backing Harris or Trump.
While Harris and Trump won't be on stage, their names are likely to get brought up a lot.
In fact, one of the top betting <a href="https://polymarket.com/markets/politics/vp-debate">odds </a>from prediction market Polymarket is on how many times the candidates will utter the names Trump and Harris.
Some of the most likely items for Vance to say during the debate according to the Polymarket odds are:
<ul>
<li>Abortion: 93%</li>
<li>Border 5+ Times: 93%</li>
<li>Trump 20+ Times: 79%</li>
<li>Harris 15+ Times: 83%</li>
<li>Inflation: 95%</li>
<li>Helene: 80% (the recent hurricane)</li>
<li>Israel: 88%</li>
</ul>
Lower betting odds, but topics that could prove to be among the most talked about are Vance saying "tampon" at 33% and saying Haitian at 28%.
Some of the most likely items for Walz to say during the debate according to Polymarket odds are:
<ul>
<li>Abortion: 94%</li>
<li>Trump 20+: 73% &nbsp;</li>
<li>Harris 15+: 77%</li>
<li>Coach: 69%</li>
<li>Teacher: 82%</li>
<li>Football: 68%</li>
<li>Helene: 54%</li>
<li>Israel: 83%</li>
</ul>
Polymarket shows a 95% chance that Walz and Vance shake hands before the debate.
Betting odds currently predict that Walz will win the debate based on YouGov polls with a 73% chance of winning.
Bettors can also predict how many people will watch the debate. Here are the current odds:
<ul>
<li>Less than 40 million viewers: 18%</li>
<li>40 million to 45 million: 14%</li>
<li>45 million to 50 million: 19%</li>
<li>50 million to 55 million: 24%</li>
<li>55 million to 60 million: 14%</li>
<li>60 to 65 million: 8%</li>
<li>65 million or more: 2%</li>
</ul>
For context, the presidential debate between Harris and Trump <a href="https://www.benzinga.com/general/entertainment/24/09/40840076/trump-vs-harris-presidential-debate-viewership-tops-trump-biden-total-but-falls-short-of-re">was watched by </a>67.1 million people on Sept. 10 and the lone vice-presidential debate between Harris and Mike Pence for the 2020 election was watched by 57.9 million people.
On Polymarket, users can deposit funds using USDC (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDC</a>) via the Polygon (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/matic/usd">MATIC</a>) network, or directly from a crypto account with Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>). In each betting market, the winning option pays out at $1.
While Trump and Harris won't take part in the debate, they could see their betting odds change after the debate. Harris currently <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40993290/trump-vs-harris-2024-election-betting-odds-show-vice-president-maintains-lead-as-race-near">leads at sportsbook</a> Bet365 with odds of -125 to Trump's +100. At Polymarket, Harris has a 50% chance of winning the 2024 election compared to 49% for Trump.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/09/41011819/trump-harris-could-appear-in-back-to-back-60-minutes-interviews-could-paramount-stock-be-a-">Trump, Harris Could Appear In Back-To-Back &#8217;60 Minutes&#8217; Interviews: Could Paramount Stock Be A 2024 Election Winner?</a></li>
</ul>
Photos: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Sports Betting

Politics

$ETH

$MATIC

$USDC

PARA

PARAA

Walz Vs. Vance VP Debate Betting Odds, What Candidate Is Favored? Plus, How To Watch, Likely Topics And More

Ellomay Capital (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELLO#AMEX">ELLO</a>) reported quarterly earnings of $0.03 per share. This is a 75 percent decrease over earnings of $0.12 per share from the same period last year. The company reported $12.07 million in sales this quarter. This is a 17.53 percent decrease over sales of $14.64 million the same period last year.

Earnings

News

ELLO

Ellomay Capital Q2 EPS $0.03 Down From $0.12 YoY, Sales $12.07M Down From $14.64M YoY

Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) founder <a href="https://www.benzinga.com/topic/jeff-bezos">Jeff Bezos</a> may not be running the e-commerce company he founded anymore, but his business philosophies and principles helped lay the groundwork to create one of the largest companies in the world today.
Tips on how to conduct meetings for increased productivity could be one of the ways that Bezos and Amazon have been successful over the years. 
What Happened:&nbsp;Bezos is one of the <a href="https://www.benzinga.com/general/education/24/08/40300456/jeff-bezos-may-be-worth-186b-but-he-once-paid-600k-a-month-in-rent-to-a-legendary-musician">richest people in the world</a> today and a large portion of his wealth came from the increased valuation at Amazon over the years, a company that survived the dot-com bubble and has diversified into new sectors like streaming and the cloud. 
The wealth increase was driven by an increase in the valuation of Amazon over the years, the company&nbsp;Bezos led for 27 years before stepping down as&nbsp;<a href="https://www.benzinga.com/general/education/22/11/29691021/walking-away-on-top-if-you-invested-1-000-in-amazon-when-bezos-stepped-down-heres-how-much-youd" target="_blank" rel="noreferrer noopener">CEO in July 2021.</a>
One of the reasons Amazon might&nbsp;be so successful could have been Bezos' leadership and business practices.
A company such as Amazon likely held many meetings between executives, employees and potential partners. One practice Bezos did during meetings with employees was to speak last, something his current girlfriend Lauren Sánchez recently said was one of the best business lessons she's learned from him.
"I hold a lot of meetings, and I would talk first in a meeting, and (Bezos) goes, ‘No, no, no. You're the boss. You talk last. You let everyone else talk, so that they don't get swayed by your opinion,'" Sánchez <a href="https://www.wsj.com/articles/lauren-sanchez-interview-jeff-bezos-11674587199" target="_blank" rel="noreferrer noopener">said </a>in an interview with the Wall Street Journal.
Sánchez said living with Bezos has been like "having a master class every day."
"What he's taught me a lot about is management."
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important:&nbsp;Bezos&nbsp;previously shared that changing practices for meetings helped with the success of Amazon and could have been "the smartest thing we ever did" at the company.
Bezos shared in 2018 that Amazon did away with PowerPoint presentations, choosing instead to open meetings with a 30-minute silent reading period. This gave employees time to read through a detailed memo that covered the discussion topics prior to the start of the meeting.
Similar to the Bezos&#8217;s speaking last, these meetings would see employees share reactions to the memo before the CEO would share his own thoughts.
Bezos said the silent reading helped create "the context for what will then be a good discussion."
The former Amazon CEO said the silent reading period also ensured that attendees read through the notes rather than ignoring emails.
"Executives will bluff their way through the meeting as if they've read the memo, because we're busy, and so you've got to actually carve out the time for the memo to get read."
Bezos also recommended&nbsp;keeping meetings as short as possible once the silent reading period is done. Sanchez said Bezos told her the key was to keep meetings under an hour if possible.
CNBC&nbsp;<a href="https://www.cnbc.com/2019/10/14/jeff-bezos-this-is-the-smartest-thing-we-ever-did-at-amazon.html" target="_blank" rel="noreferrer noopener">reported&nbsp;</a>that other business leaders such as&nbsp;Twitter&nbsp;co-founder and former CEO&nbsp;Jack Dorsey&nbsp;also shared a similar belief in starting meetings with a silent reading period to go over the meeting agenda.
"This practice makes time for everyone to get on the same page, allows us to work from many locations, and gets to truth/critical thinking faster," Dorsey&nbsp;said.
The business advice from Bezos could be worth it for bosses and companies to consider with Amazon shares up 945% in the past 10 years and the company now one of the largest in the world. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/09/40860724/bezos-doesnt-sunbathe-alone-on-his-25m-a-year-superyacht-as-he-hosts-kim-kardashian-leonard">Bezos Doesn&#8217;t Sunbathe Alone On His $25M-A-Year Superyacht As He Hosts Kim Kardashian, Leonardo DiCaprio, Katy Perry, Orlando Bloom And Others For Summer Fun</a></li>
</ul>
This article was previously published by Benzinga and has been updated.
Photo: Shutterstock

Education

Management

Success Stories

AMZN

Jeff Bezos Used This Method To Get True Opinions From Employees: Amazon Founder Says 'You're The Boss'

As consumers embrace pesticide-free food for its health and taste benefits, Autumn Brands is bringing similar clean practices to cannabis. The women-owned, family-operated company based in Santa Barbara California is setting new standards in sustainable, pesticide-free cultivation.
Co-founded by Autumn Shelton, chief financial officer and partner, alongside the Brand family -Hans, Johnny and Hannah Brand &#8211; Autumn Brands is making a name for itself with its dedication to health, wellness and environmental responsibility. 
In an exclusive interview with Benzinga Cannabis, Shelton shared the journey from traditional agriculture to cannabis and the challenges of running a pesticide-free operation.
Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. You can&#8217;t afford to miss out if you're serious about the business.
<h3 class="wp-block-heading">From Daisies To Dank: The Bloom Of Autumn Brands</h3>
<a href="https://autumnbrands.com/">Autumn Brands</a> started as a cut flower business growing Gerber daisies, but as competition from South America increased, the team realized they needed to pivot. "My partner Hans had owned this property for over 30 years, and the cut flower industry was struggling," said Shelton. "We saw the legalization of cannabis as an opportunity to transition. So we flipped the operation from cut flowers to cannabis."
But it wasn't just a matter of switching crops.&nbsp;
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="683" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30122039/001-1-1024x683.jpg" alt="" class="wp-image-572863" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30122039/001-1-1024x683.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30122039/001-1-300x200.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30122039/001-1-768x512.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30122039/001-1-1536x1024.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30122039/001-1.jpg 1620w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Courtesy of Autumn Brands </figcaption></figure>
Shelton and her team took it a step further by deciding to grow <a href="https://www.benzinga.com/topic/california-cannabis">cannabis </a>without the use of any pesticides &#8211; organic or otherwise. "Hans came to me in 2017 and said, ‘I want to stop spraying pesticides,' and I said, ‘I love this idea, but how are we going to do it?'" she told Benzinga. 
After some research and a hefty investment in beneficial insects, the team made the transition. "We threw away tens of thousands of plants until the ladybugs colonized the greenhouses," she said, "and we've been 100% pesticide-free ever since."
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/09/41057685/federal-health-agencies-must-take-stronger-role-in-u-s-cannabis-policy-shift-new-report-says">Federal Health Agencies Must Take Stronger Role In U.S. Cannabis Policy Shift, New Report Says</a>
<h3 class="wp-block-heading">Pesticide-Free Cannabis: A Market Niche Ready To Grow</h3>
Shelton said the market for pesticide-free cannabis is only going to grow as consumers become more educated about what's in their products. 
"People didn't realize they were smoking cannabis with pesticides before legalization, but now they're starting to understand the importance of clean cannabis," she said. "Recent <a href="https://www.benzinga.com/markets/cannabis/24/07/39584632/mold-and-yeast-sixth-marijuana-recall-this-year-hits-colorado-cannabis-dispensaries">recalls </a>over pesticide contamination have raised awareness, and we're seeing a movement toward more pesticide-free products."
But scaling a pesticide-free operation remains a challenge. "It's more <a href="https://www.benzinga.com/general/biotech/24/09/40754415/transforming-a-5-000-year-old-craft-how-weed-companies-use-data-to-make-hash-without-losing-its-a">artisanal</a>," Shelton said. "We've had to create this perfect ecosystem in our greenhouses where beneficial insects can thrive, but it's not easy to replicate at scale. That's why we're still searching for partners who can match our standards."
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="621" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30122131/Autumn-Family-no-Logo-2-1024x621.jpg" alt="" class="wp-image-572865" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30122131/Autumn-Family-no-Logo-2-1024x621.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30122131/Autumn-Family-no-Logo-2-300x182.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30122131/Autumn-Family-no-Logo-2-768x465.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30122131/Autumn-Family-no-Logo-2-1536x931.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30122131/Autumn-Family-no-Logo-2.jpg 1782w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Courtesy of Autumn Brands </figcaption></figure>
<h3 class="wp-block-heading">Scaling Sustainability</h3>
"One of the hardest things was learning how to combat pests like mites without using chemicals," Shelton said. "We had to figure out new ways to manage it without compromising the quality of our product."
Despite these challenges, Shelton emphasized the long-term benefits of going pesticide-free. "We've saved money by not having to worry about recalls or heavy metal contamination. It also creates a perfect ecosystem in the greenhouse where beneficial insects thrive, reducing the need for constant pest management." 
Read Also: <a href="https://www.benzinga.com/general/biotech/24/09/40820581/want-organic-cannabis-operators-are-turning-to-this-tech-to-save-millions-and-get-certified">Want Organic Cannabis? Operators Are Turning To This Tech To Save Millions And Get Certified</a>
<h3 class="wp-block-heading">Expanding Beyond California: What's Next?</h3>
Autumn Brands operates on five and a half acres of greenhouse space, producing flowers, pre-rolls and wellness products such as pain-relieving elixirs. The company also offers self-care products focused on intimate wellness, tapping into a growing market segment.
Though deeply rooted in California, Shelton said Autumn Brands is looking to expand beyond the state through <a href="https://www.benzinga.com/cannabis/deals">licensing deals</a> for their products. "The flower side is a little more challenging because it is not easy to find operators who can grow 100% pesticide-free at scale," she said. Nevertheless, the company sees significant opportunities for its products in other states.
"We're also building out a hemp line focused on minor cannabinoids like <a href="https://www.benzinga.com/general/biotech/23/10/35300227/from-cbn-cbg-to-thcv-consumer-centric-brands-embrace-rare-cannabinoids-for-differentiation">CBG and CBN</a>, which are challenging to incorporate into cannabis products due to the small quantities present," Shelton explained.&nbsp;
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="1024" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30122233/Autumn-Brands-Mini-Hinged-Lid-Tin-Sativa-1024x1024.png" alt="" class="wp-image-572867" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30122233/Autumn-Brands-Mini-Hinged-Lid-Tin-Sativa-1024x1024.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30122233/Autumn-Brands-Mini-Hinged-Lid-Tin-Sativa-300x300.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30122233/Autumn-Brands-Mini-Hinged-Lid-Tin-Sativa-150x150.png 150w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30122233/Autumn-Brands-Mini-Hinged-Lid-Tin-Sativa-768x768.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30122233/Autumn-Brands-Mini-Hinged-Lid-Tin-Sativa.png 1080w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Courtesy of Autumn Brands </figcaption></figure>
<h3 class="wp-block-heading">New Markets&nbsp;</h3>
As a member of the California Cannabis Industry Association, Shelton has had a front-row seat to the regulatory struggles faced by the industry. "There's been a huge disconnect between government and the industry, and I think that's one of the biggest lessons other states can learn from <a href="https://www.benzinga.com/topic/california-cannabis">California</a>," she said. "We've gone through over-regulation, high taxes, and oversupply, which have all contributed to the challenges we face today."
Looking to expand into new markets, Shelton said her focus is on states that have learned from California's missteps. "We're looking at <a href="https://www.benzinga.com/markets/cannabis/23/11/35662129/are-traditional-cannabis-licensing-models-obsolete-how-reverse-licensing-can-help">new state markets</a>. Relationships are key for us—finding partners who share our ethos is the most important factor when deciding where to expand."
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="683" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30122315/Hans-Brand-Hanna-Brand-Johnny-Brand-Autumn-Shelton-1024x683.jpg" alt="" class="wp-image-572868" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30122315/Hans-Brand-Hanna-Brand-Johnny-Brand-Autumn-Shelton-1024x683.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30122315/Hans-Brand-Hanna-Brand-Johnny-Brand-Autumn-Shelton-300x200.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30122315/Hans-Brand-Hanna-Brand-Johnny-Brand-Autumn-Shelton-768x512.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30122315/Hans-Brand-Hanna-Brand-Johnny-Brand-Autumn-Shelton-1536x1024.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/30122315/Hans-Brand-Hanna-Brand-Johnny-Brand-Autumn-Shelton.jpg 1620w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Hans Brand, Hanna Brand, Johnny Brand, Autumn Shelton -Courtesy of Autumn Brands. </figcaption></figure>
Shelton remains optimistic about the future of the company and the cannabis industry. "We're constantly innovating and looking for ways to expand while staying true to our values," she said. "Whether it's through our pesticide-free flower, wellness products, or hemp line, we're committed to offering high-quality, clean cannabis to our customers."
Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/09/40886620/how-this-former-dea-consultant-is-making-craft-cannabis-profitable-in-new-jersey-a-dirt-y-little">How This Former DEA Consultant Is Making Craft Cannabis Profitable In New Jersey: A &#8216;Dirt-y&#8217; Little Secret</a>

Biotech

Cannabis

Market Summary

Entrepreneurship

Small Business

Exclusives

Interview

Pesticide-Free Food Tastes Better—Wait Until You Try Clean Cannabis This Autumn

The basketball-focused podcast &#8220;All the Smoke,&#8221; which interviewed Kobe Bryant several weeks before his untimely 2020 death, has since exploded in popularity featuring celebs and sports icons. On Monday, the <a href="https://www.youtube.com/watch?v=bzThwqnQJDY">podcast</a> took it up a notch with its release of a sit-down interview with Vice President <a href="https://www.benzinga.com/topic/kamala-harris">Kamala Harris</a>.
Podcast hosts and former NBA players Matt Barnes and Stephen Jackson talked with Harris about policy issues, the economy, upcoming elections, social justice and more. Naturally, cannabis legalization also came up in the 47-minute conversation.
The Washington Post called nabbing Harris for an interview a &#8220;coup for a podcast with popularity that has remained largely confined to sports and entertainment.&#8221; That said, &#8220;All the Smoke&#8217;s&#8221; YouTube channel has more than a million subscribers, so the feeling was likely mutual.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Kamala Harris x All the Smoke drops Monday 10am ET on Youtube / AllTheSmokeProductions. <a href="https://t.co/NK9dmIveXw">pic.twitter.com/NK9dmIveXw</a>
&mdash; All the Smoke Productions (@allthesmokeprod) <a href="https://twitter.com/allthesmokeprod/status/1840438423296864685?ref_src=twsrc%5Etfw">September 29, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/09/41096880/gop-senator-leads-bipartisan-effort-to-seal-low-level-marijuana-possession-records-providing-sec">GOP Senator Leads Bipartisan Effort To Seal Low-Level Marijuana Possession Records, Providing &#8216;Second Chance&#8217;</a>
<h1 class="wp-block-heading">It's Time To Legalize</h1>
Harris said the time has come to legalize marijuana, essentially marking the first time the vice president has publicly discussed her position on cannabis legalization since becoming the Democratic <a href="https://www.benzinga.com/markets/cannabis/24/07/39874209/joe-biden-drops-out-what-would-happen-with-cannabis-legalization-under-kamala-harris-or-donald-t">presidential nominee</a> in late July.
"I just feel strongly, people should not be going to jail for smoking weed. And we know historically what that has meant and who has gone to jail," Harris told Barnes and Jackson.
Harris was apparently referring to the racial disparity in cannabis-possession arrests. On average, Black people are 3.6 times more likely to be arrested on marijuana charges, according to ACLU data.
"Second, I just think we have come to a point where we have to understand that we need to legalize it and stop criminalizing this behavior," she said. "And actually, this is not a new position for me. I have felt for a long time we need to legalize. So that's where I am on that."
The episode came out just one day before the first and probably only debate between the vice-presidential nominees, Minnesota Gov. Tim Walz (D) and former president Donald Trump's VP  pick, Sen. <a href="https://www.washingtonpost.com/jd-vance/?itid=lk_inline_manual_7" target="_blank" rel="noreferrer noopener">JD Vance</a> of Ohio.
<h1 class="wp-block-heading">Trump's Remarks On Harris&#8217; Racial Identity</h1>
Barnes mentioned Donald Trump&#8217;s snide comments on Harris&#8217; racial identity and asked how she felt about &#8220;people questioning the fabric of who you are.&#8221;
Harris, whose mother is of Indian descent and whose father is Jamaican, seemed unfazed.
&#8220;I'm really clear about who I am and if anybody else is not, they need to go through their own level of therapy, that's not my issue,&#8221; she said.
Meanwhile, Harris is ahead of Trump by three percentage points according to Monday&#8217;s<a href="https://www.nytimes.com/interactive/2024/us/elections/polls-president.html"> New York Times's average of national polls</a> that show the race is still tight in the seven key battleground states.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/09/41080016/trump-bashes-harris-border-visit-immigration-policy-worst-crisis-in-history-of-world-its-an-inva">Trump Bashes Harris&#8217; Border Visit &amp; Immigration Policy: &#8216;Worst Crisis&#8217; In History Of World, &#8216;It&#8217;s An Invasion&#8217;</a></li>
</ul>
Photo: All the Smoke YouTube channel

Government

Legal

Sports

Media

Kamala Harris: 'We Need to Legalize' Cannabis, VP Says For First Time As Presidential Candidate In 'All The Smoke' Podcast

On Monday, Gov. Gavin Newsom (D) signed a bill allowing licensed cannabis lounges to sell food and host ticketed events, essentially giving birth to <a href="https://www.benzinga.com/markets/cannabis/24/08/40638186/in-amsterdam-style-california-senate-moves-to-legalize-cannabis-farmers-markets-and-cafes">Amsterdam-style cannabis cafes </a>
These venues will allow patrons to enjoy marijuana while eating food in the same establishment—a major shift for California&#8217;s cannabis scene, SFGate <a href="https://www.sfgate.com/cannabis/article/newsom-signs-celebrity-backed-cannabis-cafe-bill-19804371.php">reported.</a>
See Also: <a href="https://www.benzinga.com/markets/cannabis/24/09/41012794/gov-newsoms-hemp-ban-goes-into-effect-consequences-for-industry-investors-patients">Gov. Newsom&#8217;s Hemp Ban Goes Into Effect: Consequences For Industry, Investors, Patients</a>
The state&#8217;s existing laws permit individuals to consume cannabis inside licensed lounges, but these businesses have been prohibited from offering food.
With the new legislation, customers will no longer need to step out of the lounge in search of a meal or snack, creating a more integrated and enjoyable experience.
<h3 class="wp-block-heading">Celebrities Weigh In </h3>
Several high-profile names have supported this effort, including actors Whoopi Goldberg, <a href="https://www.benzinga.com/markets/cannabis/24/09/40844998/woody-harrelson-pushes-gov-newsom-to-approve-cannabis-cafes-in-california">Woody Harrelson</a>, and comedian Bill Maher. 
"It makes no sense that we don't let cannabis lounges sell food. Right now, California makes it harder to get high at a lounge and eat a sandwich than to drive a car, but guess which one is more dangerous?" Maher said In a public statement before the bill was signed.
Both Goldberg and Harrelson, who have their own cannabis ventures in California, stand to benefit from the law, which will no doubt boost the cannabis hospitality industry.
<h3 class="wp-block-heading">Local Control Still A Hurdle</h3>
While this new law represents a step forward, it comes with a catch: local governments will have the final say on whether or not cannabis cafes can open in their jurisdictions.
In many parts of the state, cannabis lounges remain banned, limiting where these new social consumption spaces can operate. 
At the moment, cities like San Francisco, West Hollywood and Palm Springs are home to more than a dozen lounges, but it remains unclear how quickly other cities will embrace the change.
Ellen Komp, deputy director of California&#8217;s National Organization for the Reform of Marijuana Laws (NORML) stated that while the law takes effect on January 1, local governments may require additional regulations before lounges can begin serving food.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/05/38947483/california-lawmakers-back-cannabis-cafes-to-help-tax-burdened-businesses">California Lawmakers Back Cannabis Cafes To Help Tax-Burdened Businesses</a></li>
</ul>

Amsterdam-Style Cannabis Cafes Coming To California With Celebrity Backing: Here's Who Pushed For The Bill

Wedbush analyst Dan Ives is out with a new note laying the groundwork for Tesla Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) highly anticipated robotaxi event, expected to introduce new <a href="https://www.benzinga.com/news/24/09/41086839/tesla-cybertruck-starts-receiving-highly-anticipated-fsd-software">&#8220;game changing&#8221; technology</a>.
What To Know: Ives released a new note to clients late Monday, reiterating Tesla with an Outperform rating and price target of $300 ahead of the EV company&#8217;s long-awaited &#8220;We, Robot&#8221; event set for Oct. 10.
&#8220;We believe Robotaxi Day will be seminal and historical day for Musk and Tesla and marks a new chapter of growth around autonomous, FSD, and AI future at Tesla,&#8221; Ives said in a note to clients. 
The Wedbush analyst anticipated several &#8220;game changing&#8221; updates and details surrounding Tesla&#8217;s robotaxi platform, rumored to be called the &#8220;Cybercab.&#8221; Ives laid out expectations for updates on scaling the Cybercab, overall costs per mile, a potential ride-share app and a first-gen demonstration.
Given the anticipation surrounding the event, Ives expects CEO Elon Musk to address near-term investor concerns related to the robotaxi and explain the company&#8217;s longer-term vision for the technology. 
Check This Out: <a href="https://www.benzinga.com/general/entertainment/24/09/41101369/tesla-ev-fire-in-garage-goes-viral-during-hurricane-helene-while-cybertruck-owners-engage-w">Tesla EV Fire In Garage Goes Viral During Hurricane Helene, While Cybertruck Owners Engage Wade Mode</a>
Tesla is also likely to focus on recent breakthroughs with its full self-driving (FSD) software and <a href="http://benzinga.com/topic/ai">AI</a> initiatives. Tesla&#8217;s FSD has now logged over 1.5 billion miles in Tesla&#8217;s datacenters and the company&#8217;s latest FSD release has been deemed a significant upgrade over its predecessor, Ives said.
FSD 13 is expected to be released before the end of the year. The Wedbush analyst will be watching for any updates on the next release, which is expected to introduce new features like autonomous parking and reversing capabilities and offer a 6x improvement in miles-per-intervention. 
Ives also noted Tesla&#8217;s <a href="http://benzinga.com/topic/optimus">Optimus</a> bot continues to pique interest. Tesla is currently targeting sales of its humanoid robots by 2026. The analyst anticipates updates on Optimus development at next week&#8217;s robotaxi event.
&#8220;We believe this is a pivotal time for Tesla as the company prepares to release its years of Robotaxi R&amp;D shadowed behind the curtains, while Musk &amp; Co. lay out the company's vision for the future,&#8221; Ives said.
&#8220;We remain confident in the Tesla story which has proven successful many times over the years, and we look forward to this long-awaited event as the next evolution of transportation unfolds.&#8221;
TSLA Price Action: Tesla shares are up approximately 22% over the past month. The stock closed Tuesday up 0.45% at $261.63, according to<a href="http://pro.benzinga.com"> Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/09/41086839/tesla-cybertruck-starts-receiving-highly-anticipated-fsd-software">Tesla Cybertruck Starts Receiving Highly Anticipated FSD Software</a></li>
</ul>
Photo: Courtesy of Tesla.

Analyst Color

Events

Tech

TSLA

Tesla Analyst Sets The Stage For 'Game Changing' Robotaxi Event, Anticipates 'Seminal And Historical Day For Musk And Tesla'

Baxter International Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAX#NYSE">BAX</a>). has shut down its largest manufacturing facility following significant damage caused by Hurricane Helene. The hurricane, which hit the Southeast of the U.S. with deadly force, triggered power outages and flooding across the region.
Baxter's North Cove plant, located in Marion, North Carolina, is the nation's biggest producer of intravenous and peritoneal dialysis solutions. The company has stated that this disruption will likely have a negative effect on its financial performance.
On Monday, Baxter's shares initially fell as much as 4.1%, but later settled at a 2.3% decline, trading at $38.01 by midday in New York. Baxter&#8217;s stock ended up closing right below $38 a share Monday. Read Also: <a href="https://www.benzinga.com/news/24/09/41082452/hurricane-helene-exposes-vulnerability-of-floridas-home-insurance-market">Hurricane Helene Exposes Vulnerability Of Florida&#8217;s Home Insurance Market</a> Patrick Wood, an equity analyst at Morgan Stanley, covered the hurricane-related disruption in a note Monday, outlining the potential financial harm caused by the storm. Wood pointed to a 2017 hurricane, which impacted Baxter&#8217;s capacity in Puerto Rico, as a precedent for Hurricane Helene. &#8220;To sense check, if we assumed a $140mn impact in BAX's Q4 (given Q3 is essentially over), that implies about 4 days worth of shutdown for the entire US Chronic Therapies and Infusion Therapies businesses,&#8221; Wood wrote in the note. &#8220;Though in reality more given this is unlikely the only facility where PD and IV solutions are produced and BAX can presumably shift capacity around.&#8221;
Hurricane Helene, a Category 4 storm, struck Florida on Thursday with winds reaching 140 miles per hour and moved northward. The storm caused severe flooding, including a levee breach that sent water into Baxter&#8217;s facility. The flooding damaged stock and raw materials, according to a company spokesperson.
It remains unclear if the plant closure will affect medical procedures in the U.S., though Wells Fargo analysts noted that other companies, such as ICU Medical, Fresenius Kabi and B Braun SE, may be able to compensate for Baxter's supply loss.
Baxter is working closely with local officials to bring the North Cove plant back online. Fortunately, none of the facility's 2,500 employees were injured. However, the company is still verifying the safety of its workforce as communication in the area has been hampered by outages in cellular service. Keep Reading: • <a href="https://www.benzinga.com/24/09/41082266/hurricane-helene-devastates-southeastern-u-s-slamming-infrastructure-and-leaving-millions-powerless">Hurricane Helene Devastates Southeastern U.S., Slamming Infrastructure And Leaving Millions Powerless</a>

Photo: Unsplash

Health Care

Trading Ideas

Hurricane Helene Shutters Baxter International's Key Manufacturing Hub In North Carolina

NXRT

NexPoint Residential Trust Says Its Properties Did Not Sustain Any Material Damages Due To Hurricane Helene

First Security Bancorp and its wholly owned subsidiary, First Security Trust and Savings Bank, will combine with Byline Bancorp, Inc. in a cash and stock transaction valued at approximately&nbsp;$41.0 million&nbsp;based upon Byline&#39;s closing stock price as of September 27, 2024.
Under the terms of the definitive merger agreement, at the closing of the transaction, Byline will issue 2.1794 shares of its common stock for each outstanding share of First Security Bancorp common stock, or approximately 1.5 million shares to First Security Bancorp common stockholders, subject to adjustment per the terms of the agreement.
Based upon the closing price of Byline&#39;s common stock of&nbsp;$26.16&nbsp;on September 27, 2024, this represents a transaction value of approximately&nbsp;$38.4 million&nbsp;or&nbsp;$57.01&nbsp;per First Security Bancorp common share.&nbsp;
Outstanding First Security Bancorp preferred shares will be redeemed in cash at closing with an estimated aggregate value of approximately&nbsp;$2.6 million&nbsp;in accordance with the terms of the certificate of designation.

Byline Bancorp, First Security Bancorp Enter Definitive Merger Agreement; First Security To Combine With Byline Bancorp In Cash And Stock Transaction Valued At $41M

Apparel company Nike Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) will report first-quarter financial results Tuesday on the heels of recently naming a new CEO. Shares could be volatile after<a href="https://www.benzinga.com/earnings"> the earnings report.</a>
Earnings Estimates: Analysts expect the company to report first-quarter revenue of $11.64 billion, down from $12.94 billion in last year's first quarter, according to data<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent093024&amp;t=be2bearmibe3na1"> from Benzinga Pro.</a>
The company has missed revenue estimates from analysts in three of the last four quarters but beaten estimates in seven of the last 10 quarters overall.
Analysts expect the company to report first-quarter earnings per share of 52 cents, down from 94 cents in last year's first quarter. The company has beaten analyst estimates for earnings per share in four straight quarters and nine of the last 10 quarters overall.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40964381/nike-ceo-announcement-icing-on-the-cake-for-bulls-8-analysts-react-to-elliot-hills-">Nike CEO Announcement &#8216;Icing On The Cake&#8217; For Bulls: 8 Analysts React To Elliot Hill&#8217;s Ascension</a>
What Analysts Are Saying: With the announcement that Elliot Hill is <a href="https://www.benzinga.com/news/24/09/40948580/nike-stock-jumps-9-after-the-bell-ceo-set-to-retire">returning to the company</a> and will be the new CEO, analysts have been raising their price targets.
Jefferies analyst Randal Konik maintained a Hold rating and raised the price target for Nike from $80 to $85 ahead of the earnings report.
"We believe investor expectations for F1Q are fairly low, as foot/web traffic data has remained soft and competitors continue to gain share," Konik said.
The analyst said there's "not much to get excited about yet" for Nike, but the incoming CEO will change things.
Hill's impact may not be felt until fiscal 2026, the analyst cautioned.
"Therefore, NKE shares are in ‘no man's land' and likely remain range-bound for a number of quarters."
Hill re-joining Nike is a positive development, the analyst added, with the change potentially improving culture and the company's wholesale channel.
"However, we are wary of ongoing challenges he will face."
One of the biggest catalysts for Nike is coming with an analyst day in November. The analyst said the analyst day, the company's first in seven years, could be pushed out with the change.
In the earnings report, Nike is likely to talk about the new Air Max and could also highlight upcoming products, the analyst added.
"While Nike is beginning a new multi-year product innovation cycle in 2H24, we foresee headwinds as the company works to control its current product assortment and wholesale partnerships."
Stifel analyst Jim Duffy recently maintained a Hold rating with a $79 price target.
The analyst said bringing back a long-time Nike insider should be viewed as a positive.
&#8220;Recent underperformance is a direct result of losing focus on what has made Nike great for so many years,&#8221; Duffy said. &#8220;Under Mr. Hill&#8217;s leadership, we hope to see a revitalization of the Nike culture and a renaissance in innovation and design.&#8221;
The analyst warns that changing CEOs can reset financial forecasts, trigger periods of product revitalization and potentially lead to additional management changes.
Key Items to Watch: While all the talk about Nike will be on the incoming CEO, the company likely won't share much new information about this leadership change before the move happens in mid-October.
Instead, investors will likely focus on the top- and bottom-line numbers with recent quarters showing strength in earnings per share and weakness in revenue versus Street estimates.
One of the biggest focuses from investors and analysts outside of the new CEO will likely be on the regional results. The fourth-quarter results showed strength in China and weakness in North America.
NKE Price Action: Nike stock was down 1.16% to $88.40 at market close on Monday versus a 52-week trading range of $70.75 to $123.39. Nike stock is down 17% year-to-date in 2024.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40957353/nikes-new-ceo-elliott-hill-to-focus-on-repairing-retailer-relations">Nike&#8217;s New CEO Elliott Hill To Focus On Repairing Retailer Relations</a></li>
</ul>
Photo: Shutterstock

Price Target

Previews

Reiteration

Analyst Ratings

Nike Q1 Earnings Preview: China, North America In Focus, Analyst Says 'Not Much To Get Excited About Yet' With CEO Change

The shares are expected to begin trading on the Nasdaq Capital Market under the ticker symbol &quot;HTLM&quot; on October 1, 2024. The Offering is expected to close on October 2, 2024, subject to customary closing conditions.

IPOs

HTLM

HomesToLife Prices IPO Of An Aggregate Of 1.25M Ordinary Shares At $4.00 Per Share

Trump Media &amp; Technology Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) shares traded nearly 9% higher Monday as the stock continues to move on volatility <a href="https://www.benzinga.com/government/24/09/41093811/whats-going-on-with-trump-media-technology-stock-on-monday">ahead of the Presidential election.</a>
The Details: Trump Media &amp; Technology shares have gained more than 30% over the past five days as the lockup period expiration date passed. 
Trump Media co-founders Andrew Litinsky and Wes Moss's United Atlantic Ventures sold over seven million shares of Trump Media last week. However, Trump maintained his plans not to sell his stake in the Truth Social parent and did not sell any shares. 
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/41071876/mojo-is-back-at-tesla-says-tech-analyst-dan-ives-ahead-of-q3-deliveries">Tesla &#8216;Mojo Is Back,&#8217; Tech Analyst Dan Ives Says Ahead Of Q3 Deliveries</a>
What Else: Trump Media &amp; Technology announced after Monday's closing bell that its custom-built content delivery network (CDN) is <a href="https://www.benzinga.com/pressreleases/24/09/g41104106/trump-media-expands-tv-streaming-delivery-network-to-multi-site-operation">now operating</a> from multiple geographic sites across the country.
&#8220;We&#8217;re pleased to report our CDN is operating excellently and is quickly enhancing,&#8221; said TMTG CEO Devin Nunes. &#8220;With additional data centers expected to open soon, our TV streaming capabilities and content are expanding rapidly, consistent with Truth Social&#8217;s goal to become the unassailable fortress of free speech on the Internet.&#8221;
The content delivery network is currently accessible through the Truth Social platform and scheduled to be released soon as a stand-alone app. TMTG said it aims to create a robust TV streaming platform offering news, Christian content and family-friendly programming. 
DJT Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Trump Media &amp; Technology Group shares are up 1.68% at $16.32 after-hours after climbing 8.95% in Monday's regular trading session.
Read Also:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/41070564/amazon-prime-day-data-insights-before-october-event-apple-purchases-up-22-celsius-tops-grocery-categ">Amazon Prime Day Data Insights Before October Event: Apple Purchases Up 22%, Celsius Tops Grocery Category</a></li>
</ul>
Photo: Pete Linforth from Pixabay

After-Hours Center

Movers

What Happened With Trump Media & Technology Stock Today?

Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) has outperformed the market over the past 5 years by 6.82% on an annualized basis producing an average annual return of 21.1%. Currently, Fluor has a market capitalization of $8.17 billion. 
Buying $1000 In FLR: If an investor had bought $1000 of FLR stock 5 years ago, it would be worth $2,644.68 today based on a price of $47.71 for FLR at the time of writing.
<h3>Fluor's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727731818_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Fluor 5 Years Ago Would Be Worth This Much Today

Global Payments (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPN#NYSE">GPN</a>) has outperformed the market over the past 20 years by 2.4% on an annualized basis producing an average annual return of 10.85%. Currently, Global Payments has a market capitalization of $25.70 billion. 
Buying $100 In GPN: If an investor had bought $100 of GPN stock 20 years ago, it would be worth $777.09 today based on a price of $101.00 for GPN at the time of writing.
<h3>Global Payments's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727731813_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Global Payments 20 Years Ago Would Be Worth This Much Today

Billionaire Mark Cuban recently <a href="https://www.benzinga.com/24/09/41075742/mark-cuban-as-treasury-secretary-no-head-of-the-sec-is-the-job-hed-take-because-gary-gensler-has-bee">expressed interest in leading</a> the Securities and Exchange Commission (SEC), criticizing the agency&#8217;s handling of cryptocurrency regulations under current Chair Gary Gensler.
As a well-known NBA team owner and <a href="https://www.benzinga.com/markets/cryptocurrency/21/03/20070630/dogecoin-gets-mark-cuban-boost-but-its-no-match-to-this-nft-cryptos-spiciness">advocate for digital assets</a> like Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>), Cuban has frequently used his platform, along with Tesla CEO Elon Musk, to influence the meme coin's price through public support.
Here's a look at how investing in Dogecoin based on a Cuban event would have turned out.
What Happened: On March 4, 2021, <a href="http://www.benzinga.com/markets/cryptocurrency/21/03/20021204/mark-cubans-dallas-mavericks-now-accept-meme-crypto-dogecoin">Cuban announced that</a> the National Basketball Association's Dallas Mavericks would accept Dogecoin as payment for tickets and merchandise.
"The Dallas Mavericks are a long-time enthusiast of cryptocurrency, opening up new opportunities for the team to sell tickets and merchandise to its global MFFL fan base," said BitPay CEO Stephen Pair at the time. BitPay worked with the Mavericks to make the move happen.
Check This Out:
<ul>
<li>Lawmakers Made Huge Investments This Year. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent093024" target="_blank" rel="noreferrer noopener">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
One of the biggest explanations Cuban gave as to why the Mavericks made the decision to accept Dogecoin was "Because we can!" "The Mavericks have decided to accept Dogecoin as payment for Mavs tickets and merchandise for on very important, earth shattering reason, because we can!" Cuban said at the time.
Cuban said sometimes you have to do fun things that could generate a lot of PR for your company or team.
The Mavericks saw $122,000 r<a href="http://'Supply And Demand Is Undefeated': Mark Cuban Celebrates Dallas Mavericks' Dogecoin Merch Sales">ecognized in Dogecoin sales </a>over its first month and set several 24-hour records with strong demand for using the meme coin towards merchandise.
Cuban <a href="http://www.benzinga.com/markets/cryptocurrency/21/08/22504769/mark-cuban-reveals-how-much-dogecoin-he-owns">revealed later in 2021</a> that he personally owned $494 in Dogecoin, and the Mavericks own whatever they have collected from the merchandise and ticket sales.
"If I had to choose between buying a lottery ticket and #Dogecoin… I would buy #Dogecoin," Cuban tweeted in February 2021.
Supporting Dogecoin even further, the Mavericks<a href="https://www.benzinga.com/markets/cryptocurrency/21/08/22709857/dallas-mavericks-offering-25-gift-cards-for-customers-buying-merch-with-dogecoin-during-do"> offered a promotion </a>to support the meme crypto in August 2021. All customers who used Dogecoin to make purchases online totaling $150 or more received a free $25 e-gift card. The event was part of a Dogemania event.
The early support for Dogecoin and the promotion by the Mavericks wasn't lost on Dogecoin co-founder Billy Markus.
"If you wanna support one of the first big name vendors to evangelize DOGE for purchases, as @mcuban says, it's ready for you," Markus tweeted at the time.
Investing With Cuban, the Mavericks: Sometimes big events in the cryptocurrency or Dogecoin world can be catalysts that drive the price higher.
Dogecoin hit a high of $.05109 on the day of the Maverick's March announcement. A $1,000 investment in Dogecoin at the time could have purchased 19,573.30 Dogecoin.
Based on a <a href="http://www.benzinga.com/money/todays-dogecoin-price/">price </a>of $0.1185 for Dogecoin at the time of writing, the same $1,000 investment would be worth $2,319.44 today. This marks a +131.9% over the last three and a half years. 
Dogecoin <a href="https://www.benzinga.com/markets/cryptocurrency/21/12/24814327/2021-was-the-year-of-dogecoin-a-month-by-month-retrospective-with-top-stories">hit an all-time high</a> of $0.7375 in May 2021, a couple of months after the Mavericks began supporting the cryptocurrency. At its peak, the $1,000 investment based on the March announcement was worth $14,435.31.
Dogecoin has traded between $0.05747 and $0.2266 over the last 52 weeks. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/41096120/if-you-invested-1-000-in-bitcoin-when-donald-trump-said-he-wasnt-a-fan-heres-how-much-youd">If You Invested $1,000 In Bitcoin When Donald Trump Said He Wasn&#8217;t A Fan, Here&#8217;s How Much You&#8217;d Have Today</a></li>
</ul>
Photo: Courtesy of&nbsp;<a href="https://www.flickr.com/photos/gageskidmore/" target="_blank" rel="noreferrer noopener">Gage Skidmore</a>&nbsp;on flickr

Topics

$DOGE

If You Invested $1,000 In Dogecoin When Mark Cuban And The Dallas Mavericks Welcomed The Meme Crypto, Here's How Much You'd Have Now

Offerings

Terex Prices Private Offering Of $750M Of 6.250% Senior Notes Due 2032 At Par

The Company anticipates that these cost reductions will result in overhead savings of&nbsp;$54 million&nbsp;on an annualized run-rate basis and will lower the Company&#39;s revenue break-even point from less than&nbsp;$430 million&nbsp;of annual revenue to less than&nbsp;$225 million&nbsp;of annual revenue.
The company continues to expect revenue in the range of&nbsp;$97 million&nbsp;to&nbsp;$107 million

Guidance

The Beachbody Company, Inc. Class A Common Stock

BODI

Beachbody's MLM Network To Begin Winding Down; Reaffirms Its Financial Guidance For Q3, With Revenue At $97M - $107M, Est $103.586M

BODi will transition from its current Multi-Level Marketing (MLM) Network channel to a single-level Affiliate Program, which will launch November 1, 2024.
Current participants in the Team BODi Partner Network in the United States and Canada will transition to the new Affiliate Program that is focused on being more productive and rewarding for a larger group of sellers.
&nbsp;

Beachbody Expects To Significantly Improve Revenue Break-Even Point, Decreasing From Less Than $430M In Annual Revenue To Less Than $225M

HCW Biologics (HCWB) has released an update. HCW Biologics Inc. successfully secured a $2.5 million investment by selling 1,785,718 shares at $1.40...

HCW Biologics Executives Boost Investment with Share Purchase

HCW Biologics GAAP EPS of -$0.15, revenue of $1.3M

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
HCW Biologics (NASDAQ:<a href="https://investorplace.com/stock-quotes/hcwb-stock-quote/">HCWB</a>) just reported results for the fourth quarter of 2023.<ul><li>HCW Biologics reported earnings per share of -30 cents. This was below the analyst estimate for EPS of -14 cents.</li><li>The company reported revenue of $560,360.</li><li>This was 37.74% worse than the analyst estimate for revenue of $900,000.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/04/hcwb-stock-earnings-hcw-biologics-for-q4-of-2023/">HCWB Stock Earnings: HCW Biologics Misses EPS, Misses Revenue for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

HCWB Stock Earnings: HCW Biologics Misses EPS, Misses Revenue for Q4 2023

HCW Biologics (HCWB – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Michael Okunewitch...

HCW Biologics: A Strong Buy on Promising Clinical Results and Strategic Advancements

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
HCW Biologics (NASDAQ:<a href="https://investorplace.com/stock-quotes/hcwb-stock-quote/">HCWB</a>) just reported results for the first quarter of 2024.<ul><li>HCW Biologics reported earnings per share of -20 cents.</li><li>The company reported revenue of $1.13 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/hcwb-stock-earnings-hcw-biologics-for-q1-of-2024/">HCWB Stock Earnings: HCW Biologics Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

HCWB Stock Earnings: HCW Biologics Reported Results for Q1 2024

HCW Biologics GAAP EPS of -$0.14, revenue of $1.1M

Michael Okunewitch, an analyst from Maxim Group, maintained the Buy rating on HCW Biologics (HCWB – Research Report). The associated price target r...

HCW Biologics: A Promising Buy Rating Based on Clinical Advancements and Strategic Growth Opportunities

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
HCW Biologics (NASDAQ:<a href="https://investorplace.com/stock-quotes/hcwb-stock-quote/">HCWB</a>) just reported results for the second quarter of 2024.<ul><li>HCW Biologics reported earnings per share of -40 cents.</li><li>The company reported revenue of $618,854.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/hcwb-stock-earnings-hcw-biologics-for-q2-of-2024/">HCWB Stock Earnings: HCW Biologics Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

HCWB Stock Earnings: HCW Biologics Reported Results for Q2 2024

HCW Biologics reports Q2 results

HCWB

Press Releases

Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting

Investigator Sponsor of HCW Biologics' Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting

Comments

HCW Biologics

Interés en corto

HCW Biologics (NASDAQ:HCWB) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL